Replies to post #169908 on Biotech Values

[DewDiligence]

Interesting that in this [ag-biotech] space there is a 6-year product development cycle.

It’s more similar to the drug-development cycle than many investors realize. Projects are designated phase-1, phase-2, phase-3, and phase-4, with the designations being roughly similar to the those in drug development.

E.g., here’s MON’s pipeline update from Jan 2013: #msg-83244701.

[genisi]

Evogene

The specific traits/genes under investigation and development are not mentioned that I have seen

Genes are not disclosed but you can see traits here:

http://www.evogene.com/Products/List

You can also look in their PR for more details like in this one:

http://www.evogene.com/News-Events/News